OTC鎮痛剤の世界市場の評価：薬剤タイプ別、投与経路別、流通チャネル別、地域別、機会、予測（2017年～2031年）

世界のOTC鎮痛剤の市場規模は、2023年の300億4,000万米ドルから2031年に419億1,000万米ドルに達すると予測され、予測期間の2024年～2031年にCAGRで4.25%の成長が見込まれます。市場の拡大は、疼痛管理に対する消費者の意識の高まり、OTC医薬品へのアクセスの容易さ、セルフメディケーションの人気の高まりによるものと考えられます。さらに、OTC鎮痛剤の高いコスト効率、老年人口の増加、さまざまな疾患の有病率の増加は、世界のOTC鎮痛剤市場の拡大にプラスの影響を与えています。

さらに、主要製薬企業による鎮痛剤の普及に向けた取り組みの高まりも、市場に有利な成長機会をもたらしています。2023年3月、消費者向けセルフケア製品の主要企業の1つであるPerrigo Company plcは、イブプロフェンとアセトアミノフェン錠剤の略式新薬承認申請（ANDA）が米国食品医薬品局（FDA）から承認されたと発表しました。この処方薬からOTCへの承認により、同社の開発・規制能力が強化され、ビジネスを急成長させ、消費者の要求に応えることができるようになっています。

さらに、セルフメディケーションへの選好の高まりは、世界のOTC鎮痛剤市場の主要促進要因の1つです。患者は、その便利な性質とライフスタイルの複雑化により、軽度の症状を効果的に管理するためにセルフメディケーションを選ぶようになってきています。OTC鎮痛剤は、医療従事者にかかることなく、費用と時間をかけずに疼痛管理を行うことができることから、この増加がOTC鎮痛剤の需要を押し上げています。OTC鎮痛剤へのアクセスのしやすさとオンライン薬局の急速な拡大も、世界のOTC鎮痛剤需要を後押ししています。特にオンライン薬局は、消費者に価格を比較させ、詳細な製品の説明を提供することで、十分な情報に基づいた意思決定を支援するため、OTC鎮痛剤の普及に大きな役割を果たすと予測されます。

当レポートでは、世界のOTC鎮痛剤市場について調査分析し、市場規模と予測、市場力学、主要企業の情勢などを提供しています。

目次

第1章 プロジェクトの範囲と定義

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 世界のOTC鎮痛剤市場の見通し（2017年～2031年）

• 市場規模の分析と予測
  • 金額
• 市場シェアの分析と予測
  • 薬剤タイプ別
  • 投与経路別
  • 流通チャネル別
  • 地域別
  • 市場シェア分析：企業別（金額）（上位5社とその他 - 2023年）
• 市場マップ分析（2023年）
  • 薬剤タイプ別
  • 投与経路別
  • 流通チャネル別
  • 地域別

第5章 北米のOTC鎮痛剤市場の見通し（2017年～2031年）

• 市場規模の分析と予測
  • 金額
• 市場シェアの分析と予測
  • 薬剤タイプ別
  • 投与経路別
  • 流通チャネル別
  • シェア：国別
• 各国の市場の評価
  • 米国の鎮痛剤市場の見通し（2017年～2031年）
  • カナダ
  • メキシコ

第6章 欧州のOTC鎮痛剤市場の見通し（2017年～2031年）

• ドイツ
• フランス
• イタリア
• 英国
• ロシア
• オランダ
• スペイン
• ポーランド

第7章 アジア太平洋のOTC鎮痛剤市場の見通し（2017年～2031年）

• インド
• 中国
• 日本
• オーストラリア
• ベトナム
• 韓国
• インドネシア
• フィリピン

第8章 南米のOTC鎮痛剤市場の見通し（2017年～2031年）

• ブラジル
• アルゼンチン

第9章 中東・アフリカのOTC鎮痛剤市場の見通し（2017年～2031年）

• サウジアラビア
• アラブ首長国連邦
• 南アフリカ
• イスラエル

第10章 需給分析

第11章 輸入と輸出の分析

第12章 バリューチェーン分析

第13章 ポーターのファイブフォース分析

第14章 PESTLE分析

第15章 価格分析

第16章 市場力学

• 市場促進要因
• 市場の課題

第17章 市場の動向と発展

第18章 規制枠組みとイノベーション

• 臨床試験
• 規制当局の承認

第19章 特許情勢

第20章 ケーススタディ

第21章 競合情勢

• マーケットリーダー上位5社の競合マトリクス
• 上位5社のSWOT分析
• 主要企業上位10社の情勢
  • Novartis AG
  • Boehringer Ingelheim International GmbH
  • Endo, Inc.
  • Bayer AG
  • Johnson & Johnson Services, Inc.
  • Groupe Sanofi
  • Teva Pharmaceutical Industries Ltd.
  • Haleon plc
  • Viatris Inc.
  • Reckitt Benckiser Group PLC

第22章 戦略的推奨

第23章 当社について、免責事項

List of Tables

• Table 1. Pricing Analysis of Products from Key Players
• Table 2. Competition Matrix of Top 5 Market Leaders
• Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
• Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

• Figure 1. Global Over-the-Counter (OTC) Analgesics Market, By Value, In USD Billion, 2017-2031F
• Figure 2. Global Over-the-Counter (OTC) Analgesics Market Share (%), By Drug Type, 2017-2031F
• Figure 3. Global Over-the-Counter (OTC) Analgesics Market Share (%), By Route of Administration, 2017-2031F
• Figure 4. Global Over-the-Counter (OTC) Analgesics Market Share (%), By Distribution Channel, 2017-2031F
• Figure 5. Global Over-the-Counter (OTC) Analgesics Market Share (%), By Region, 2017-2031F
• Figure 6. North America Over-the-Counter (OTC) Analgesics Market, By Value, In USD Billion, 2017-2031F
• Figure 7. North America Over-the-Counter (OTC) Analgesics Market Share (%), By Drug Type, 2017-2031F
• Figure 8. North America Over-the-Counter (OTC) Analgesics Market Share (%), By Route of Administration, 2017-2031F
• Figure 9. North America Over-the-Counter (OTC) Analgesics Market Share (%), By Distribution Channel, 2017-2031F
• Figure 10. North America Over-the-Counter (OTC) Analgesics Market Share (%), By Country, 2017-2031F
• Figure 11. United States Over-the-Counter (OTC) Analgesics Market, By Value, In USD Billion, 2017-2031F
• Figure 12. United States Over-the-Counter (OTC) Analgesics Market Share (%), By Drug Type, 2017-2031F
• Figure 13. United States Over-the-Counter (OTC) Analgesics Market Share (%), By Route of Administration, 2017-2031F
• Figure 14. United States Over-the-Counter (OTC) Analgesics Market Share (%), By Distribution Channel, 2017-2031F
• Figure 15. Canada Over-the-Counter (OTC) Analgesics Market, By Value, In USD Billion, 2017-2031F
• Figure 16. Canada Over-the-Counter (OTC) Analgesics Market Share (%), By Drug Type, 2017-2031F
• Figure 17. Canada Over-the-Counter (OTC) Analgesics Market Share (%), By Route of Administration, 2017-2031F
• Figure 18. Canada Over-the-Counter (OTC) Analgesics Market Share (%), By Distribution Channel, 2017-2031F
• Figure 19. Mexico Over-the-Counter (OTC) Analgesics Market, By Value, In USD Billion, 2017-2031F
• Figure 20. Mexico Over-the-Counter (OTC) Analgesics Market Share (%), By Drug Type, 2017-2031F
• Figure 21. Mexico Over-the-Counter (OTC) Analgesics Market Share (%), By Route of Administration, 2017-2031F
• Figure 22. Mexico Over-the-Counter (OTC) Analgesics Market Share (%), By Distribution Channel, 2017-2031F
• Figure 23. Europe Over-the-Counter (OTC) Analgesics Market, By Value, In USD Billion, 2017-2031F
• Figure 24. Europe Over-the-Counter (OTC) Analgesics Market Share (%), By Drug Type, 2017-2031F
• Figure 25. Europe Over-the-Counter (OTC) Analgesics Market Share (%), By Route of Administration, 2017-2031F
• Figure 26. Europe Over-the-Counter (OTC) Analgesics Market Share (%), By Distribution Channel, 2017-2031F
• Figure 27. Europe Over-the-Counter (OTC) Analgesics Market Share (%), By Country, 2017-2031F
• Figure 28. Germany Over-the-Counter (OTC) Analgesics Market, By Value, In USD Billion, 2017-2031F
• Figure 29. Germany Over-the-Counter (OTC) Analgesics Market Share (%), By Drug Type, 2017-2031F
• Figure 30. Germany Over-the-Counter (OTC) Analgesics Market Share (%), By Route of Administration, 2017-2031F
• Figure 31. Germany Over-the-Counter (OTC) Analgesics Market Share (%), By Distribution Channel, 2017-2031F
• Figure 32. France Over-the-Counter (OTC) Analgesics Market, By Value, In USD Billion, 2017-2031F
• Figure 33. France Over-the-Counter (OTC) Analgesics Market Share (%), By Drug Type, 2017-2031F
• Figure 34. France Over-the-Counter (OTC) Analgesics Market Share (%), By Route of Administration, 2017-2031F
• Figure 35. France Over-the-Counter (OTC) Analgesics Market Share (%), By Distribution Channel, 2017-2031F
• Figure 36. Italy Over-the-Counter (OTC) Analgesics Market, By Value, In USD Billion, 2017-2031F
• Figure 37. Italy Over-the-Counter (OTC) Analgesics Market Share (%), By Drug Type, 2017-2031F
• Figure 38. Italy Over-the-Counter (OTC) Analgesics Market Share (%), By Route of Administration, 2017-2031F
• Figure 39. Italy Over-the-Counter (OTC) Analgesics Market Share (%), By Distribution Channel, 2017-2031F
• Figure 40. United Kingdom Over-the-Counter (OTC) Analgesics Market, By Value, In USD Billion, 2017-2031F
• Figure 41. United Kingdom Over-the-Counter (OTC) Analgesics Market Share (%), By Drug Type, 2017-2031F
• Figure 42. United Kingdom Over-the-Counter (OTC) Analgesics Market Share (%), By Route of Administration, 2017-2031F
• Figure 43. United Kingdom Over-the-Counter (OTC) Analgesics Market Share (%), By Distribution Channel, 2017-2031F
• Figure 44. Russia Over-the-Counter (OTC) Analgesics Market, By Value, In USD Billion, 2017-2031F
• Figure 45. Russia Over-the-Counter (OTC) Analgesics Market Share (%), By Drug Type, 2017-2031F
• Figure 46. Russia Over-the-Counter (OTC) Analgesics Market Share (%), By Route of Administration, 2017-2031F
• Figure 47. Russia Over-the-Counter (OTC) Analgesics Market Share (%), By Distribution Channel, 2017-2031F
• Figure 48. Netherlands Over-the-Counter (OTC) Analgesics Market, By Value, In USD Billion, 2017-2031F
• Figure 49. Netherlands Over-the-Counter (OTC) Analgesics Market Share (%), By Drug Type, 2017-2031F
• Figure 50. Netherlands Over-the-Counter (OTC) Analgesics Market Share (%), By Route of Administration, 2017-2031F
• Figure 51. Netherlands Over-the-Counter (OTC) Analgesics Market Share (%), By Distribution Channel, 2017-2031F
• Figure 52. Spain Over-the-Counter (OTC) Analgesics Market, By Value, In USD Billion, 2017-2031F
• Figure 53. Spain Over-the-Counter (OTC) Analgesics Market Share (%), By Drug Type, 2017-2031F
• Figure 54. Spain Over-the-Counter (OTC) Analgesics Market Share (%), By Route of Administration, 2017-2031F
• Figure 55. Spain Over-the-Counter (OTC) Analgesics Market Share (%), By Distribution Channel, 2017-2031F
• Figure 56. Turkey Over-the-Counter (OTC) Analgesics Market, By Value, In USD Billion, 2017-2031F
• Figure 57. Turkey Over-the-Counter (OTC) Analgesics Market Share (%), By Drug Type, 2017-2031F
• Figure 58. Turkey Over-the-Counter (OTC) Analgesics Market Share (%), By Route of Administration, 2017-2031F
• Figure 59. Turkey Over-the-Counter (OTC) Analgesics Market Share (%), By Distribution Channel, 2017-2031F
• Figure 60. Poland Over-the-Counter (OTC) Analgesics Market, By Value, In USD Billion, 2017-2031F
• Figure 61. Poland Over-the-Counter (OTC) Analgesics Market Share (%), By Drug Type, 2017-2031F
• Figure 62. Poland Over-the-Counter (OTC) Analgesics Market Share (%), By Route of Administration, 2017-2031F
• Figure 63. Poland Over-the-Counter (OTC) Analgesics Market Share (%), By Distribution Channel, 2017-2031F
• Figure 64. South America Over-the-Counter (OTC) Analgesics Market, By Value, In USD Billion, 2017-2031F
• Figure 65. South America Over-the-Counter (OTC) Analgesics Market Share (%), By Drug Type, 2017-2031F
• Figure 66. South America Over-the-Counter (OTC) Analgesics Market Share (%), By Route of Administration, 2017-2031F
• Figure 67. South America Over-the-Counter (OTC) Analgesics Market Share (%), By Distribution Channel, 2017-2031F
• Figure 68. South America Over-the-Counter (OTC) Analgesics Market Share (%), By Country, 2017-2031F
• Figure 69. Brazil Over-the-Counter (OTC) Analgesics Market, By Value, In USD Billion, 2017-2031F
• Figure 70. Brazil Over-the-Counter (OTC) Analgesics Market Share (%), By Drug Type, 2017-2031F
• Figure 71. Brazil Over-the-Counter (OTC) Analgesics Market Share (%), By Route of Administration, 2017-2031F
• Figure 72. Brazil Over-the-Counter (OTC) Analgesics Market Share (%), By Distribution Channel, 2017-2031F
• Figure 73. Argentina Over-the-Counter (OTC) Analgesics Market, By Value, In USD Billion, 2017-2031F
• Figure 74. Argentina Over-the-Counter (OTC) Analgesics Market Share (%), By Drug Type, 2017-2031F
• Figure 75. Argentina Over-the-Counter (OTC) Analgesics Market Share (%), By Route of Administration, 2017-2031F
• Figure 76. Argentina Over-the-Counter (OTC) Analgesics Market Share (%), By Distribution Channel, 2017-2031F
• Figure 77. Asia-Pacific Over-the-Counter (OTC) Analgesics Market, By Value, In USD Billion, 2017-2031F
• Figure 78. Asia-Pacific Over-the-Counter (OTC) Analgesics Market Share (%), By Drug Type, 2017-2031F
• Figure 79. Asia-Pacific Over-the-Counter (OTC) Analgesics Market Share (%), By Route of Administration, 2017-2031F
• Figure 80. Asia-Pacific Over-the-Counter (OTC) Analgesics Market Share (%), By Distribution Channel, 2017-2031F
• Figure 81. Asia-Pacific Over-the-Counter (OTC) Analgesics Market Share (%), By Country, 2017-2031F
• Figure 82. India Over-the-Counter (OTC) Analgesics Market, By Value, In USD Billion, 2017-2031F
• Figure 83. India Over-the-Counter (OTC) Analgesics Market Share (%), By Drug Type, 2017-2031F
• Figure 84. India Over-the-Counter (OTC) Analgesics Market Share (%), By Route of Administration, 2017-2031F
• Figure 85. India Over-the-Counter (OTC) Analgesics Market Share (%), By Distribution Channel, 2017-2031F
• Figure 86. China Over-the-Counter (OTC) Analgesics Market, By Value, In USD Billion, 2017-2031F
• Figure 87. China Over-the-Counter (OTC) Analgesics Market Share (%), By Drug Type, 2017-2031F
• Figure 88. China Over-the-Counter (OTC) Analgesics Market Share (%), By Route of Administration, 2017-2031F
• Figure 89. China Over-the-Counter (OTC) Analgesics Market Share (%), By Distribution Channel, 2017-2031F
• Figure 90. Japan Over-the-Counter (OTC) Analgesics Market, By Value, In USD Billion, 2017-2031F
• Figure 91. Japan Over-the-Counter (OTC) Analgesics Market Share (%), By Drug Type, 2017-2031F
• Figure 92. Japan Over-the-Counter (OTC) Analgesics Market Share (%), By Route of Administration, 2017-2031F
• Figure 93. Japan Over-the-Counter (OTC) Analgesics Market Share (%), By Distribution Channel, 2017-2031F
• Figure 94. Australia Over-the-Counter (OTC) Analgesics Market, By Value, In USD Billion, 2017-2031F
• Figure 95. Australia Over-the-Counter (OTC) Analgesics Market Share (%), By Drug Type, 2017-2031F
• Figure 96. Australia Over-the-Counter (OTC) Analgesics Market Share (%), By Route of Administration, 2017-2031F
• Figure 97. Australia Over-the-Counter (OTC) Analgesics Market Share (%), By Distribution Channel, 2017-2031F
• Figure 98. Vietnam Over-the-Counter (OTC) Analgesics Market, By Value, In USD Billion, 2017-2031F
• Figure 99. Vietnam Over-the-Counter (OTC) Analgesics Market Share (%), By Drug Type, 2017-2031F
• Figure 100. Vietnam Over-the-Counter (OTC) Analgesics Market Share (%), By Route of Administration, 2017-2031F
• Figure 101. Vietnam Over-the-Counter (OTC) Analgesics Market Share (%), By Distribution Channel, 2017-2031F
• Figure 102. South Korea Over-the-Counter (OTC) Analgesics Market, By Value, In USD Billion, 2017-2031F
• Figure 103. South Korea Over-the-Counter (OTC) Analgesics Market Share (%), By Drug Type, 2017-2031F
• Figure 104. South Korea Over-the-Counter (OTC) Analgesics Market Share (%), By Route of Administration, 2017-2031F
• Figure 105. South Korea Over-the-Counter (OTC) Analgesics Market Share (%), By Distribution Channel, 2017-2031F
• Figure 106. Indonesia Over-the-Counter (OTC) Analgesics Market, By Value, In USD Billion, 2017-2031F
• Figure 107. Indonesia Over-the-Counter (OTC) Analgesics Market Share (%), By Drug Type, 2017-2031F
• Figure 108. Indonesia Over-the-Counter (OTC) Analgesics Market Share (%), By Route of Administration, 2017-2031F
• Figure 109. Indonesia Over-the-Counter (OTC) Analgesics Market Share (%), By Distribution Channel, 2017-2031F
• Figure 110. Philippines Over-the-Counter (OTC) Analgesics Market, By Value, In USD Billion, 2017-2031F
• Figure 111. Philippines Over-the-Counter (OTC) Analgesics Market Share (%), By Drug Type, 2017-2031F
• Figure 112. Philippines Over-the-Counter (OTC) Analgesics Market Share (%), By Route of Administration, 2017-2031F
• Figure 113. Philippines Over-the-Counter (OTC) Analgesics Market Share (%), By Distribution Channel, 2017-2031F
• Figure 114. Middle East & Africa Over-the-Counter (OTC) Analgesics Market, By Value, In USD Billion, 2017-2031F
• Figure 115. Middle East & Africa Over-the-Counter (OTC) Analgesics Market Share (%), By Drug Type, 2017-2031F
• Figure 116. Middle East & Africa Over-the-Counter (OTC) Analgesics Market Share (%), By Route of Administration, 2017-2031F
• Figure 117. Middle East & Africa Over-the-Counter (OTC) Analgesics Market Share (%), By Distribution Channel, 2017-2031F
• Figure 118. Middle East & Africa Over-the-Counter (OTC) Analgesics Market Share (%), By Country, 2017-2031F
• Figure 119. Saudi Arabia Over-the-Counter (OTC) Analgesics Market, By Value, In USD Billion, 2017-2031F
• Figure 120. Saudi Arabia Over-the-Counter (OTC) Analgesics Market Share (%), By Drug Type, 2017-2031F
• Figure 121. Saudi Arabia Over-the-Counter (OTC) Analgesics Market Share (%), By Route of Administration, 2017-2031F
• Figure 122. Saudi Arabia Over-the-Counter (OTC) Analgesics Market Share (%), By Distribution Channel, 2017-2031F
• Figure 123. UAE Over-the-Counter (OTC) Analgesics Market, By Value, In USD Billion, 2017-2031F
• Figure 124. UAE Over-the-Counter (OTC) Analgesics Market Share (%), By Drug Type, 2017-2031F
• Figure 125. UAE Over-the-Counter (OTC) Analgesics Market Share (%), By Route of Administration, 2017-2031F
• Figure 126. UAE Over-the-Counter (OTC) Analgesics Market Share (%), By Distribution Channel, 2017-2031F
• Figure 127. South Africa Over-the-Counter (OTC) Analgesics Market, By Value, In USD Billion, 2017-2031F
• Figure 128. South Africa Over-the-Counter (OTC) Analgesics Market Share (%), By Drug Type, 2017-2031F
• Figure 129. South Africa Over-the-Counter (OTC) Analgesics Market Share (%), By Route of Administration, 2017-2031F
• Figure 130. South Africa Over-the-Counter (OTC) Analgesics Market Share (%), By Distribution Channel, 2017-2031F
• Figure 131. By Drug Type Map-Market Size (USD Billion) & Growth Rate (%), 2023
• Figure 132. By Route of Administration Map-Market Size (USD Billion) & Growth Rate (%), 2023
• Figure 133. By Distribution Channel Map-Market Size (USD Billion) & Growth Rate (%), 2023
• Figure 134. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2023

Global over-the-counter (OTC) analgesics market is projected to witness a CAGR of 4.25% during the forecast period 2024-2031, growing from USD 30.04 billion in 2023 to USD 41.91 billion in 2031. The expansion of the market can be attributed to growing consumer awareness of pain management, easy accessibility to OTC drugs, and the increasing popularity of self-medication. Additionally, the cost-efficient nature of OTC analgesics, the expansion of the geriatric population, and the growing prevalence of different diseases positively influence the expansion of the global OTC analgesics market.

Furthermore, the rising efforts by the leading pharmaceutical companies to propel the availability of analgesics are also providing lucrative growth opportunities to the market. In March 2023, Perrigo Company plc, one of the leading providers of consumer self-care products, announced that they had been approved by the US Food and Drug Administration (FDA) for their abbreviated new drug application (ANDA) for Ibuprofen and Acetaminophen tablets. This prescription-to-OTC approval strengthens the company's development and regulatory capabilities, allowing it to grow its business at a rapid rate and meet consumer requirements.

Additionally, the growing preference for self-medication is one of the major drivers of the global Over-the-Counter (OTC) analgesics market. Patients are increasingly opting for self-medication to effectively manage minor health conditions due to its convenient nature and growing lifestyle complexities. This increase is boosting the demand for OTC analgesics as they allow individuals to manage their pain in a cost and time-efficient manner without requiring a visit to a healthcare professional. The easy accessibility to OTC analgesics coupled with the rapid expansion of online pharmacies also propels the global demand for OTC analgesics. Online pharmacies, in particular, are expected to play a significant role in boosting the reach of OTC analgesics as they allow consumers to compare prices and provide detailed product descriptions, aiding them in making informed decisions.

Expansion of Geriatric Population Boosts Market Demand

The rapid expansion of the geriatric population is one of the major factors boosting the global OTC analgesics market size, as the older population is more prone to chronic pain and prefers self-medication and cost-effective solutions. As per the World Health Organization (WHO) estimates, by 2030, 1 in 6 individuals across the globe will be sixty or older, propelling the demand for OTC analgesics. Persistent musculoskeletal pain is highly prevalent among the older population, and multisite pain contributes to significant disability among them. The older population is also more likely to experience chronic conditions that cause persistent pain, including osteoporosis, back pain, and arthritis, among others. Additionally, the natural wear and tear of muscles, joints, and bones coupled with age-related diseases results in higher incidences of pain among the elderly, bolstering the requirement for OTC analgesics. Furthermore, the older population prefers self-medication and relies on OTC analgesics for managing mild to moderate pain as they are readily available and do not require a prescription. This appeals to older individuals as they often require OTC solutions to address their immediate needs and discomfort and may not want to visit a physician frequently.

Rising Cases of Chronic Pain Causing Conditions Supports Market Expansion

Chronic pain is often caused by health conditions that last for a long period and can cause a hindrance for individuals to complete their daily tasks and function normally. Thus, individuals living with such conditions often rely on OTC analgesics for managing pain. The American Migraine Foundation (AMF) estimates that approximately 148 million individuals across the globe are suffering from chronic migraine. Other chronic conditions responsible for causing long-term pain include fibromyalgia, arthritis, and osteoporosis, among others. Additionally, prolonged periods of desk work, a sedentary lifestyle, and poor posture are propelling the occurrence of lifestyle-related conditions that are increasing the incidences of conditions, including musculoskeletal disorders, neck pain, and back pain, increasing the requirement for OTC analgesics. Furthermore, the rising cases of autoimmune diseases, including multiple sclerosis, lupus, and rheumatoid arthritis, which are known to cause inflammation and chronic pain, are also expected to provide lucrative growth opportunities to the market. According to the estimates of the WHO, over 1.8 million individuals across the globe have multiple sclerosis. Individuals suffering from such conditions often rely on OTC analgesics for the management of pain, thus bolstering the market's demand.

Topical Analgesics Witness Significant Growth

The increasing popularity of topical analgesics is supported by their minimal systemic absorption and localized action. Sprays, creams, gels, and patches are preferred by individuals looking for targeted pain relief and are often preferred by those suffering from sports injuries and musculoskeletal disorders, among others. Also, novel pharma company launches are supporting the segment's expansion. In September 2024, Mankind Pharma Ltd. launched Nimulid Strong, a spray and a gel formulation for addressing neck pain. This condition has a significant impact on the overall functioning of the body. With this launch, the company has entered the topical analgesics market. The product will be distributed across modern trade outlets and pharmacies across India. Such launches are expected to aid pharmaceutical companies in expanding their consumer healthcare portfolio. The introduction of novel and innovative products that redefine the topical analgesics segment is also expected to bolster the global over-the-counter (OTC) analgesics market growth. In July 2024, Wellness Formulations, LLC announced the launch of their ralli Rapid Pain Relief, which combines advanced features that consumers have been anticipating with the powerful pain relief of menthol. Ralli stands out because of its unique blend of skin conditioners and penetration enhancers that deliver effective pain relief without leaving a greasy residue that can usually be found.

North America Holds Major Market Share

The growth of North America over-the-counter analgesics market can be attributed to the rising incidences of sports-related injuries due to the growing popularity of sports activities, increasing cases of musculoskeletal diseases, well-established healthcare infrastructure, and high consumer awareness. As per the estimates of Johns Hopkins Medicine, in the United States, approximately 30 million teens and children participate in some sort of organized sports every year, and over 3.5 million injuries occur each year, thus propelling the requirement for OTC analgesics for effective pain management.

Furthermore, in the United States, the requirement for OTC analgesics is also increasing due to the rising prevalence of conditions such as back pain, arthritis, and migraines. According to the estimates of the AMF, over 37 million men, women, and children in the United States are suffering from migraine. Additionally, the easy availability of OTC analgesics through online and retail pharmacies and supermarkets supports the market's growth in North America. Meanwhile, the strong presence of leading pharmaceutical companies and market players is ensuring the availability of novel drugs in the region, positively influencing the expansion of the over-the-counter (OTC) analgesics market.

Future Market Scenario (2024-2031F)

As per the global over-the-counter analgesics market analysis, the market's demand is expected to witness significant growth in the coming years due to the rising cases of pain prevalent conditions and rapid growth of the geriatric population. The WHO estimates that by 2050, the global population accounting for individuals aged sixty and above will be 2.1 billion. This growth is expected to bolster the requirement for OTC analgesics as the older population is more prone to pains and aches. Additionally, the development of novel drug formulations, including fast-acting and sustained-release tablets, is expected to play a crucial role in the market's expansion. Moreover, the growing popularity of online pharmacies and e-commerce will provide new growth opportunities for drug manufacturers and increase consumer accessibility to a wide range of products.

Meanwhile, the market is expected to witness a shift towards organic and natural pain relief alternatives due to the increasing health consciousness among the general population and rising demand for alternatives to chemical-based medications. Key market players are also continuously investing in research and development activities to produce innovative, effective, and safer analgesics to gain a competitive edge.

Key Players Landscape and Outlook

The key players of the market are focused on selling and purchasing OTC units to utilize their resources on other products and expand their product portfolios, respectively. In October 2024, Groupe Sanofi confirmed their plans to sell a controlling stake in their OTC unit for approximately USD 17 billion (€16 billion).

Due to the rising demand for OTC analgesics, among other pharmaceutical products, market players are witnessing significant revenue growth. In August 2024, Haleon plc launched a share buyback program of up to USD 237 million (£185 million) as the company reported strong organic operating profit growth, substantial organic revenue growth, and a good first half.

Table of Contents

1. Project Scope and Definitions

2. Research Methodology

3. Executive Summary

4. Global Over-the-Counter (OTC) Analgesics Market Outlook, 2017-2031F

• 4.1. Market Size Analysis & Forecast
  • 4.1.1. By Value
• 4.2. Market Share Analysis & Forecast
  • 4.2.1. By Drug Type
    • 4.2.1.1. Acetaminophen
    • 4.2.1.2. Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
    • 4.2.1.3. Salicylates
    • 4.2.1.4. Others
  • 4.2.2. By Route of Administration
    • 4.2.2.1. Oral
    • 4.2.2.2. Parenteral
    • 4.2.2.3. Topical
  • 4.2.3. By Distribution Channel
    • 4.2.3.1. Hospital Pharmacies
    • 4.2.3.2. Retail Pharmacies
    • 4.2.3.3. Online Pharmacies
    • 4.2.3.4. Others
  • 4.2.4. By Region
    • 4.2.4.1. North America
    • 4.2.4.2. Europe
    • 4.2.4.3. Asia-Pacific
    • 4.2.4.4. South America
    • 4.2.4.5. Middle East and Africa
  • 4.2.5. By Company Market Share Analysis (Top 5 Companies and Others - By Value, 2023)
• 4.3. Market Map Analysis, 2023
  • 4.3.1. By Drug Type
  • 4.3.2. By Route of Administration
  • 4.3.3. By Distribution Channel
  • 4.3.4. By Region

5. North America Over-the-Counter (OTC) Analgesics Market Outlook, 2017-2031F*

• 5.1. Market Size Analysis & Forecast
  • 5.1.1. By Value
• 5.2. Market Share Analysis & Forecast
  • 5.2.1. By Drug Type
    • 5.2.1.1. Acetaminophen
    • 5.2.1.2. Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
    • 5.2.1.3. Salicylates
    • 5.2.1.4. Others
  • 5.2.2. By Route of Administration
    • 5.2.2.1. Oral
    • 5.2.2.2. Parenteral
    • 5.2.2.3. Topical
  • 5.2.3. By Distribution Channel
    • 5.2.3.1. Hospital Pharmacies
    • 5.2.3.2. Retail Pharmacies
    • 5.2.3.3. Online Pharmacies
    • 5.2.3.4. Others
  • 5.2.4. By Country Share
    • 5.2.4.1. United States
    • 5.2.4.2. Canada
    • 5.2.4.3. Mexico
• 5.3. Country Market Assessment
  • 5.3.1. United States Over-the-Counter (OTC) Analgesics Market Outlook, 2017-2031F*
    • 5.3.1.1. Market Size Analysis & Forecast
      • 5.3.1.1.1. By Value
    • 5.3.1.2. Market Share Analysis & Forecast
      • 5.3.1.2.1. By Drug Type
        • 5.3.1.2.1.1. Acetaminophen
        • 5.3.1.2.1.2. Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
        • 5.3.1.2.1.3. Salicylates
        • 5.3.1.2.1.4. Others
      • 5.3.1.2.2. By Route of Administration
        • 5.3.1.2.2.1. Oral
        • 5.3.1.2.2.2. Parenteral
        • 5.3.1.2.2.3. Topical
      • 5.3.1.2.3. By Distribution Channel
        • 5.3.1.2.3.1. Hospital Pharmacies
        • 5.3.1.2.3.2. Retail Pharmacies
        • 5.3.1.2.3.3. Online Pharmacies
        • 5.3.1.2.3.4. Others
  • 5.3.2. Canada
  • 5.3.3. Mexico

All segments will be provided for all regions and countries covered

6. Europe Over-the-Counter (OTC) Analgesics Market Outlook, 2017-2031F

• 6.1. Germany
• 6.2. France
• 6.3. Italy
• 6.4. United Kingdom
• 6.5. Russia
• 6.6. Netherlands
• 6.7. Spain
• 6.8. Poland

7. Asia-Pacific Over-the-Counter (OTC) Analgesics Market Outlook, 2017-2031F

• 7.1. India
• 7.2. China
• 7.3. Japan
• 7.4. Australia
• 7.5. Vietnam
• 7.6. South Korea
• 7.7. Indonesia
• 7.8. Philippines

8. South America Over-the-Counter (OTC) Analgesics Market Outlook, 2017-2031F

• 8.1. Brazil
• 8.2. Argentina

9. Middle East and Africa Over-the-Counter (OTC) Analgesics Market Outlook, 2017-2031F

• 9.1. Saudi Arabia
• 9.2. UAE
• 9.3. South Africa
• 9.4. Israel

10. Demand Supply Analysis

11. Import and Export Analysis

12. Value Chain Analysis

13. Porter's Five Forces Analysis

14. PESTLE Analysis

15. Pricing Analysis

16. Market Dynamics

• 16.1. Market Drivers
• 16.2. Market Challenges

17. Market Trends and Developments

18. Regulatory Framework and Innovation

• 18.1. Clinical Trials
• 18.2. Regulatory Approvals

19. Patent Landscape

20. Case Studies

21. Competitive Landscape

• 21.1. Competition Matrix of Top 5 Market Leaders
• 21.2. SWOT Analysis for Top 5 Players
• 21.3. Key Players Landscape for Top 10 Market Players
  • 21.3.1. Novartis AG
    • 21.3.1.1. Company Details
    • 21.3.1.2. Key Management Personnel
    • 21.3.1.3. Products and Services
    • 21.3.1.4. Financials (As Reported)
    • 21.3.1.5. Key Market Focus and Geographical Presence
    • 21.3.1.6. Recent Developments/Collaborations/Partnerships/Mergers and Acquisitions
  • 21.3.2. Boehringer Ingelheim International GmbH
  • 21.3.3. Endo, Inc.
  • 21.3.4. Bayer AG
  • 21.3.5. Johnson & Johnson Services, Inc.
  • 21.3.6. Groupe Sanofi
  • 21.3.7. Teva Pharmaceutical Industries Ltd.
  • 21.3.8. Haleon plc
  • 21.3.9. Viatris Inc.
  • 21.3.10. Reckitt Benckiser Group PLC

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

22. Strategic Recommendations

23. About Us and Disclaimer